Bonk, Inc. (NASDAQ:BNKK – Get Free Report)’s stock price reached a new 52-week low on Thursday . The company traded as low as $3.51 and last traded at $3.9082, with a volume of 253368 shares. The stock had previously closed at $4.06.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on BNKK shares. Wall Street Zen raised shares of Bonk to a “sell” rating in a report on Saturday. Weiss Ratings reiterated a “sell (d-)” rating on shares of Bonk in a research note on Monday. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has an average rating of “Sell”.
Read Our Latest Research Report on Bonk
Bonk Stock Performance
Bonk (NASDAQ:BNKK – Get Free Report) last issued its quarterly earnings data on Wednesday, November 19th. The company reported ($3.85) earnings per share for the quarter. The business had revenue of $1.51 million for the quarter.
About Bonk
Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema.
See Also
- Five stocks we like better than Bonk
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Why Amazon Could Be a $300 Stock Within Weeks
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors Upside
- There Are Different Types of Stock To Invest In
- MarketBeat Week in Review – 12/8 – 12/12
Receive News & Ratings for Bonk Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bonk and related companies with MarketBeat.com's FREE daily email newsletter.
